Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05762302 · ClinicalTrials.gov registry record · NA
The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)
A NA study of Lower Respiratory Tract Infection, sponsored by MeMed Diagnostics.
- Recruiting
- Registry status
- NA
- Development phase
- 1,316
- Enrollment target
- 10
- Study locations
NCT05762302 is a NA study of Lower Respiratory Tract Infection that is actively recruiting participants, run by MeMed Diagnostics. The registered enrollment target is 1,316 participants, above the 1,032-participant average among 3 other Lower Respiratory Tract Infection trials with a reported enrollment target (28% higher). The trial reports 10 study locations across 9 states.
The verdict
NCT05762302, a NA study of Lower Respiratory Tract Infection, is actively recruiting participants, sponsored by MeMed Diagnostics.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,316 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to demonstrate the MeMed BV can help clinicians make decisions about using antibiotics in patients with lower respiratory track infections and see how it would impact clinical outcomes, antibiotics use, hospitalizations, ED clinicians find ways to improve health and medical care.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MeMed BV test
Study Locations (10)
New York
- Maimonides Medical Center - Brooklyn
- Stony Brook University Hospital - Stony Brook
Florida
- University of Florida-Jacksonville - Jacksonville
Kansas
- University of Kansas Medical Center - Kansas City
Pennsylvania
- Philadelphia Thomas Jefferson ED - Philadelphia
South Carolina
- Medical University South Carolina - Charleston
Texas
- UT Southwestern Medical Center - Dallas
Wisconsin
- MCW - Milwaukee
North
- Carmel Medical Center - Haifa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,316 participants |
| Start Date | 2023-01-31 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05762302
The ClinicalTrials.gov registry entry for NCT05762302 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,316 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,032-participant average among 3 other Lower Respiratory Tract Infection trials with a reported enrollment target (28% higher). The listed sponsor is MeMed Diagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lower Respiratory Tract Infection appearing as the primary indexed condition, and to 1 intervention - of which MeMed BV test is the first listed.
NCT05762302 reports 10 study locations spanning 9 distinct geographic areas - top geographies include New York, Florida, Kansas.
Frequently Asked Questions
What is clinical trial NCT05762302 about?
NCT05762302 is a clinical study titled "The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)". This is a Prospective, multi-center study enrolling adults subjects presented to the ED/Urgent care, with symptoms consistent with lower respiratory infection (LRTI). The reason of this study is to demonstrate the MeMed BV can help clinicians make decisions about using antibiotics in patients with ...
What is the current status of trial NCT05762302?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,316 participants. The study started on 2023-01-31. Estimated completion is 2026-02-28.
What conditions does trial NCT05762302 study?
This clinical trial studies the following conditions: Lower Respiratory Tract Infection.
What interventions are being tested in trial NCT05762302?
The interventions under investigation include: MeMed BV test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05762302?
This trial is sponsored by MeMed Diagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05762302 being conducted?
This trial has 10 study locations across Florida, Kansas, New York, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Respiratory Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RECRUITING · Phase 3
-
RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.